1. [Acquired Epidermodysplasia Verruciformis in a Renal Transplant Patient: Case Report and Literature Review].
- Author
-
Orellana-Westermeyer V, Quiroz Palominos C, and Carreño Toro L
- Subjects
- Humans, Female, Adult, Biopsy, Everolimus therapeutic use, Everolimus adverse effects, Tacrolimus therapeutic use, Tacrolimus adverse effects, Immunocompromised Host, Epidermodysplasia Verruciformis pathology, Kidney Transplantation adverse effects, Immunosuppressive Agents adverse effects, Immunosuppressive Agents therapeutic use
- Abstract
Acquired epidermodysplasia verruciformis is a rare condition, secondary to a state of acquired immunosuppression and is characterized by a susceptibility to infection by human papillomavirus of the beta genus, which carries an increased risk of developing non-melanoma skin cancer. We report the case of a 39-year-old woman receiving a kidney transplant, treated with prednisone and tacrolimus, who after starting immunosuppressive therapy developed papules and warty plaques in the inguinal region. A skin biopsy was performed that was consistent with epidermodysplasia verruciformis, so it was decided to adjust immunosuppressive therapy to everolimus, which achieved a reduction in lesions. There are only 13 other cases of acquired epidermodysplasia verruciformis in kidney transplant recipients; to our knowledge this is the first case reported in Chile.
- Published
- 2024
- Full Text
- View/download PDF